• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.砷和马兜铃酸在化学致癌作用于上尿路尿路上皮的协同作用。
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):317-325. doi: 10.1158/1055-9965.EPI-20-1090. Epub 2020 Dec 4.
2
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。
World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.
3
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.台湾马兜铃酸相关性上尿路上皮癌:临床特征与结局。
Int J Cancer. 2013 Jul;133(1):14-20. doi: 10.1002/ijc.28013. Epub 2013 Feb 12.
4
Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.巴尔干地方性肾病与马兜铃酸的致病作用。
Semin Nephrol. 2019 May;39(3):284-296. doi: 10.1016/j.semnephrol.2019.02.007.
5
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.与马兜铃酸暴露相关的上尿路上皮癌的分子谱和尿液生物标志物。
Int J Cancer. 2022 Jan 15;150(2):374-386. doi: 10.1002/ijc.33827. Epub 2021 Oct 15.
6
Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.马兜铃酸诱导的上尿路上皮癌的潜伏期。
Front Public Health. 2023 Mar 9;11:1072864. doi: 10.3389/fpubh.2023.1072864. eCollection 2023.
7
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.芳香族二氢吡喃二酮-DNA 加合物是环境暴露于马兜铃酸的生物标志物。
Kidney Int. 2012 Mar;81(6):559-67. doi: 10.1038/ki.2011.371. Epub 2011 Nov 9.
8
Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.通过非靶向 DNA 加合物组学筛选大鼠肾脏和肝脏中的 DNA 损伤。
Chem Res Toxicol. 2024 Feb 19;37(2):340-360. doi: 10.1021/acs.chemrestox.3c00333. Epub 2024 Jan 9.
9
Aristolochic acid-associated urothelial cancer in Taiwan.台湾的马兜铃酸相关性尿路上皮癌。
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6. doi: 10.1073/pnas.1119920109. Epub 2012 Apr 9.
10
Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.罗马尼亚巴尔干地方性肾病区尿路上皮癌患者接触马兜铃酸的证据。
Environ Mol Mutagen. 2012 Oct;53(8):636-41. doi: 10.1002/em.21732. Epub 2012 Sep 17.

引用本文的文献

1
Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma.重新利用二甲双胍以改善上尿路尿路上皮癌患者的生存结局。
Cancer Med. 2025 Jan;14(1):e70567. doi: 10.1002/cam4.70567.
2
Overexpression of BMAL-1 is related to progression of urothelial carcinoma in arsenic exposure area.在砷暴露地区,BMAL-1的过表达与尿路上皮癌的进展相关。
Int Urol Nephrol. 2025 Apr;57(4):1175-1187. doi: 10.1007/s11255-024-04320-1. Epub 2024 Dec 6.
3
Update of the risk assessment of inorganic arsenic in food.食品中无机砷风险评估的更新
EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan.
4
Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.马兜铃酸诱导的上尿路上皮癌的潜伏期。
Front Public Health. 2023 Mar 9;11:1072864. doi: 10.3389/fpubh.2023.1072864. eCollection 2023.
5
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。
World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.
6
Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis.接受内镜下消融治疗的非肌层浸润性上尿路尿路上皮癌的结局:治疗权重逆概率分析
J Clin Med. 2022 Feb 27;11(5):1307. doi: 10.3390/jcm11051307.
7
Determinants and Dynamic Changes of Generic Quality of Life in Human Bladder Cancer Patients.人类膀胱癌患者总体生活质量的决定因素及动态变化
J Clin Med. 2021 Nov 23;10(23):5472. doi: 10.3390/jcm10235472.

本文引用的文献

1
Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.马兜铃酸突变特征定义了上尿路尿路上皮癌的低危亚型。
Theranostics. 2020 Mar 4;10(10):4323-4333. doi: 10.7150/thno.43251. eCollection 2020.
2
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.马兜铃酸及其衍生物广泛存在于亚洲各地和台湾的肝癌病例中。
Sci Transl Med. 2017 Oct 18;9(412). doi: 10.1126/scitranslmed.aan6446.
3
Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.人细胞中硫酸转移酶-1A1介导的马兜铃酸I和N-羟基马兜铃内酰胺I的生物活化作用
Carcinogenesis. 2016 Jul;37(7):647-655. doi: 10.1093/carcin/bgw045. Epub 2016 Apr 18.
4
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.全外显子测序揭示的马兜铃酸暴露的突变特征。
Sci Transl Med. 2013 Aug 7;5(197):197ra102. doi: 10.1126/scitranslmed.3006200.
5
Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.马兜铃酸的全基因组突变特征及其作为筛选工具的应用。
Sci Transl Med. 2013 Aug 7;5(197):197ra101. doi: 10.1126/scitranslmed.3006086.
6
Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.人类福尔马林固定石蜡包埋组织:通过质谱法进行致癌物 DNA 加合物生物监测的未开发标本。
Anal Chem. 2013 May 7;85(9):4251-8. doi: 10.1021/ac400612x. Epub 2013 Apr 10.
7
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.台湾马兜铃酸相关性上尿路上皮癌:临床特征与结局。
Int J Cancer. 2013 Jul;133(1):14-20. doi: 10.1002/ijc.28013. Epub 2013 Feb 12.
8
Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.利用超高效液相色谱/离子阱质谱联用技术对人体组织中aristolactam-DNA 加合物进行生物监测。
Chem Res Toxicol. 2012 May 21;25(5):1119-31. doi: 10.1021/tx3000889. Epub 2012 May 4.
9
Aristolochic acid-associated urothelial cancer in Taiwan.台湾的马兜铃酸相关性尿路上皮癌。
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6. doi: 10.1073/pnas.1119920109. Epub 2012 Apr 9.
10
Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.与服用含木通或防己的草药产品相关的肾衰竭风险:一项基于人群的病例对照研究。
Am J Kidney Dis. 2010 Mar;55(3):507-18. doi: 10.1053/j.ajkd.2009.10.055. Epub 2010 Feb 8.

砷和马兜铃酸在化学致癌作用于上尿路尿路上皮的协同作用。

Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.

机构信息

Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York.

出版信息

Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):317-325. doi: 10.1158/1055-9965.EPI-20-1090. Epub 2020 Dec 4.

DOI:10.1158/1055-9965.EPI-20-1090
PMID:33277322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8083126/
Abstract

BACKGROUND

Aristolochic acids (AA) and arsenic are chemical carcinogens associated with urothelial carcinogenesis. Here we investigate the combined effects of AA and arsenic toward the risk of developing upper tract urothelial carcinoma (UTUC).

METHODS

Hospital-based ( = 89) and population-based (2,921 cases and 11,684 controls) Taiwanese UTUC cohorts were used to investigate the association between exposure to AA and/or arsenic and the risk of developing UTUC. In the hospital cohort, AA exposure was evaluated by measuring aristolactam-DNA adducts in the renal cortex and by identifying A>T mutations in tumors. In the population cohort, AA exposure was determined from prescription health insurance records. Arsenic levels were graded from 0 to 3 based on concentrations in well water and the presence of arseniasis-related diseases.

RESULTS

In the hospital cohort, 43, 26, and 20 patients resided in grade 0, 1+2, and 3 arseniasis-endemic areas, respectively. Aristolactam-DNA adducts were present in >90% of these patients, indicating widespread AA exposure. A>T mutations in were detected in 28%, 44%, and 22% of patients residing in grade 0, 1+2, and 3 arseniasis-endemic areas, respectively. Population studies revealed that individuals who consumed more AA-containing herbs had a higher risk of developing UTUC in both arseniasis-endemic and nonendemic areas. Logistic regression showed an additive effect of AA and arsenic exposure on the risk of developing UTUC.

CONCLUSIONS

Exposure to both AA and arsenic acts additively to increase the UTUC risk in Taiwan.

IMPACT

This is the first study to investigate the combined effect of AA and arsenic exposure on UTUC.

摘要

背景

马兜铃酸(AA)和砷是与尿路上皮癌发生相关的化学致癌物质。在此,我们研究了 AA 和砷联合作用对发展为上尿路尿路上皮癌(UTUC)的风险。

方法

我们使用基于医院的(=89)和基于人群的(2921 例病例和 11684 例对照)台湾 UTUC 队列来研究 AA 和/或砷暴露与发展为 UTUC 的风险之间的关联。在医院队列中,通过测量肾皮质中的马兜铃酸-DNA 加合物和鉴定肿瘤中的 A>T 突变来评估 AA 暴露。在人群队列中,通过处方健康保险记录确定 AA 暴露。根据井水浓度和是否存在砷相关疾病,将砷水平从 0 到 3 进行分级。

结果

在医院队列中,分别有 43、26 和 20 名患者居住在砷疫区 0、1+2 和 3 级地区。>90%的患者存在马兜铃酸-DNA 加合物,表明广泛存在 AA 暴露。居住在砷疫区 0、1+2 和 3 级地区的患者中,分别有 28%、44%和 22%的患者存在 中的 A>T 突变。人群研究表明,在砷疫区和非疫区,摄入更多含有 AA 的草药的个体患 UTUC 的风险更高。Logistic 回归显示 AA 和砷暴露对发展为 UTUC 的风险具有相加效应。

结论

暴露于 AA 和砷会协同作用,增加台湾 UTUC 的风险。

影响

这是第一项研究 AA 和砷暴露联合作用对 UTUC 的影响的研究。